[1] Cabrera S, Mercé J, de Castro R, et al. Pacemaker clinic:an opportunity to detect silent atrial fibrillation and improve antithrombotic treatment[J]. Europace, 2011, 13(11):1574-1579. [2] Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke[J]. N Engl J Med, 2012, 366(2):120-129. [3] Sciacqua A, Perticone M, Tripepi G, et al. Renal disease and left atrial remodeling predict atrial fibrillation in patients with cardiovascular risk factors[J]. Int J Cardiol, 2014, 175(1):90-95. [4] Gonzalez M, Keating RJ, Markowitz SM, et al. Newly de-tected atrial high rate episodes predict long-term mortality out-comes in patients with permanent pacemakers[J]. Heart Rhythm, 2014, 11(12):2214-2221. [5] Boriani G, Glotzer TV, Santini M, et al. Device-detected a-trial fibrillation and risk for stroke:an analysis of > 10, 000 patients from the SOS AF project (Stroke preventiOn Strate-gies based on Atrial Fibrillation information from implanted devices)[J]. Eur Heart J, 2014, 35(8):508-516. [6] Mittal S, Stein K, Gilliam FR 3rd, et al. Frequency, dura-tion, and predictors of newly-diagnosed atrial fibrillation fol-lowing dual-chamber pacemaker implantation in patients with-out a previous history of atrial fibrillation[J]. Am J Cardiol, 2008, 102(4):450-453. [7] Fleischmann KE, Orav EJ, Lamas GA, et al. Atrial fibrilla-tion and quality of life after pacemaker implantation for sick sinus syndrome:data from the Mode Selection Trial (MOST)[J]. Am Heart J, 2009, 158(1):78-83. [8] Khurram IM, Maqbool F, Berger RD, et al. Association Be-tween Left Atrial Stiffness Index and Atrial Fibrillation Recur-rence in Patients Undergoing Left Atrial Ablation[J]. Circ Arrhythm Electrophysiol, 2016, 9(3):e003163. [9] Park J, Yang PS, Kim TH, et al. Low Left Atrial Compli-ance Contributes to the Clinical Recurrence of Atrial Fibrilla-tion after Catheter Ablation in Patients with Structurally and Functionally Normal Heart[J]. PLoS One, 2015, 10(12):e0143853. [10] January CT, Wann LS, Alpert JS, et al. 2014AHA/ACC/HRS guideline for the management of patients with atrial fib-rillation:executive summary:a report of the American Col-lege of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society[J]. Circu-lation, 2014, 130(23):2071-2104. [11] Krishnamoorthy S, Khoo CW, Lim HS, et al. Predictive value of atrial high-rate episodes for arterial stiffness and en-dothelial dysfunction in dual-chamber pacemaker patients[J]. Eur J Clin Invest, 2014, 44(1):13-21. [12] Kaireviciute D, Lip GY, Balakrishnan B, et al. Intracardiac expression of markers of endothelial damage/dysfunction, in-flammation, thrombosis, and tissue remodeling, and the de-velopment of postoperative atrial fibrillation[J]. J Thromb Haemost, 2011, 9(12):2345-2352. [13] Gasparovic H, Cikes M, Kopjar T, et al. Atrial apoptosis and fibrosis adversely affect atrial conduit, reservoir and con-tractile functions[J]. Interact Cardiovasc Thorac Surg, 2014, 19(2):223-230. |